Jun Miyazaki

2.4k total citations
98 papers, 1.1k citations indexed

About

Jun Miyazaki is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jun Miyazaki has authored 98 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 25 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Jun Miyazaki's work include Bladder and Urothelial Cancer Treatments (36 papers), Urinary and Genital Oncology Studies (20 papers) and Testicular diseases and treatments (17 papers). Jun Miyazaki is often cited by papers focused on Bladder and Urothelial Cancer Treatments (36 papers), Urinary and Genital Oncology Studies (20 papers) and Testicular diseases and treatments (17 papers). Jun Miyazaki collaborates with scholars based in Japan, United States and Switzerland. Jun Miyazaki's co-authors include Hiroyuki Nishiyama, Koji Kawai, Hideyuki Akaza, Akira Joraku, Ikuya Yano, Takahiro Kojima, Mizuki Onozawa, Hideyoshi Harashima, Tomokazu Kimura and Takashi Nakamura and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jun Miyazaki

88 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Miyazaki Japan 18 598 265 221 214 194 98 1.1k
A.B. Alexandroff United Kingdom 15 547 0.9× 210 0.8× 655 3.0× 238 1.1× 55 0.3× 41 1.3k
Solange Romagnoli Italy 18 217 0.4× 239 0.9× 254 1.1× 293 1.4× 185 1.0× 35 1.0k
Christine Gan United Kingdom 13 453 0.8× 501 1.9× 90 0.4× 214 1.0× 64 0.3× 24 1.1k
Di Song China 15 136 0.2× 224 0.8× 164 0.7× 160 0.7× 136 0.7× 61 807
Howard M. Radwin United States 12 480 0.8× 130 0.5× 119 0.5× 135 0.6× 170 0.9× 27 781
Silvio Altarac Croatia 15 386 0.6× 136 0.5× 80 0.4× 116 0.5× 101 0.5× 38 934
Ioannis Kotsantis Greece 16 149 0.2× 348 1.3× 137 0.6× 533 2.5× 334 1.7× 56 1.2k
Valentina Benedetti Italy 20 333 0.6× 643 2.4× 80 0.4× 224 1.0× 160 0.8× 38 1.2k
Ebru Zemheri Türkiye 15 195 0.3× 168 0.6× 85 0.4× 102 0.5× 104 0.5× 109 803
Fabio Massimo Magliocca Italy 18 629 1.1× 237 0.9× 60 0.3× 110 0.5× 122 0.6× 54 1.2k

Countries citing papers authored by Jun Miyazaki

Since Specialization
Citations

This map shows the geographic impact of Jun Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Miyazaki more than expected).

Fields of papers citing papers by Jun Miyazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Miyazaki. The network helps show where Jun Miyazaki may publish in the future.

Co-authorship network of co-authors of Jun Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Miyazaki. A scholar is included among the top collaborators of Jun Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Miyazaki. Jun Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yun, et al.. (2024). The emotional impact of uncomplicated urinary tract infections in women in China and Japan: a qualitative study. BMC Women s Health. 24(1). 94–94. 1 indexed citations
2.
Matsuzaki, Junichi, Akito Yamaguchi, Koichiro Wada, et al.. (2022). Japanese linguistic validation of the ureteral stent symptom questionnaire. International Journal of Urology. 29(4). 332–336. 1 indexed citations
3.
MASAKI, NORIYUKI, Yutaka Yonemura, Yutaro Kubota, et al.. (2022). The First Mouse Model of Meckel’s Diverticulum Carcinoma. In Vivo. 36(4). 1603–1607.
4.
Kawahara, Takashi, Takahiro Kojima, Shuya Kandori, et al.. (2019). TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer. PLoS ONE. 14(8). e0220173–e0220173. 4 indexed citations
5.
Yoshino, Takayuki, Jun Miyazaki, Takahiro Kojima, et al.. (2019). Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model. PLoS ONE. 14(1). e0209196–e0209196. 10 indexed citations
6.
7.
Kojima, Takahiro, Koji Kawai, Jun Miyazaki, & Hiroyuki Nishiyama. (2016). Biomarkers for precision medicine in bladder cancer. International Journal of Clinical Oncology. 22(2). 207–213. 29 indexed citations
8.
Kikuchi, Eiji, Jun Miyazaki, Kazuyuki Yuge, et al.. (2015). Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experience. Japanese Journal of Clinical Oncology. 46(2). hyv180–hyv180. 17 indexed citations
9.
Miyazaki, Jun, Takamitsu Inoue, Susumu Kageyama, et al.. (2015). Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomes. Japanese Journal of Clinical Oncology. 45(9). 867–873. 15 indexed citations
10.
Kawai, Koji, Tomomi Kamba, Keiji Uchida, et al.. (2014). Risk Factors for Loss to Follow-up During Active Surveillance of Patients with Stage I Seminoma. Japanese Journal of Clinical Oncology. 44(4). 355–359. 8 indexed citations
11.
Ikeda, Atsushi, Tomokazu Kimura, Mizuki Onozawa, et al.. (2014). Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan. Prostate International. 2(1). 19–25.
12.
Takaoka, Eiichiro, Yoshiyuki Matsui, Takamitsu Inoue, et al.. (2013). Risk Factors for Intravesical Recurrence in Patients with High-grade T1 Bladder Cancer in the Second TUR Era. Japanese Journal of Clinical Oncology. 43(4). 404–409. 15 indexed citations
13.
Miyazaki, Jun, et al.. (2013). Assessment and Management of Renal Impairment in Chemotherapy for Urogenital Cancer. Japanese Journal of Clinical Oncology. 43(11). 1055–1063. 4 indexed citations
14.
Miyazaki, Jun, Shiro Hinotsu, Seiji Naito, et al.. (2013). Adverse Reactions Related to Treatment Compliance During BCG Maintenance Therapy for Non-muscle-invasive Bladder Cancer. Japanese Journal of Clinical Oncology. 43(8). 827–834. 13 indexed citations
15.
Nishizawa, Haruki, Hidehito Inagaki, Manami Suzuki, et al.. (2013). Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia. Placenta. 34(12). 1202–1210. 21 indexed citations
16.
Kawai, Koji, Jun Miyazaki, Akira Joraku, Hiroyuki Nishiyama, & Hideyuki Akaza. (2012). Bacillus Calmette–Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine. Cancer Science. 104(1). 22–27. 129 indexed citations
17.
Shirakawa, Toshiro, Masaaki Matsumoto, Shinichi Morishita, et al.. (2010). UP-2.76: A comparative study on the clinical effects of silodosin and naftopidil in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia. Urology. 76(3). S106–S106. 2 indexed citations
18.
Joraku, Akira, Koji Kawai, Takahiro Yamamoto, et al.. (2008). Immunoprotection against murine bladder carcinoma by octaarginine‐modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette‐Guérin. British Journal of Urology. 103(5). 686–693. 23 indexed citations
19.
Shimazui, Toru, Kazuhiro Yoshikawa, Kazuhiko Uchida, et al.. (2007). Prediction of in vitro response to interferon‐α in renal cell carcinoma cell lines. Cancer Science. 98(4). 529–534. 3 indexed citations
20.
Miyazaki, Jun. (2002). Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. FEMS Immunology & Medical Microbiology. 33(1). 23–26. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.B. Alexandroff Breakdown of academic impact, for papers by Solange Romagnoli Breakdown of academic impact, for papers by Christine Gan Breakdown of academic impact, for papers by Di Song Breakdown of academic impact, for papers by Howard M. Radwin Breakdown of academic impact, for papers by Silvio Altarac Breakdown of academic impact, for papers by Ioannis Kotsantis Breakdown of academic impact, for papers by Valentina Benedetti Breakdown of academic impact, for papers by Ebru Zemheri Breakdown of academic impact, for papers by Fabio Massimo Magliocca
Rankless by CCL
2026